Dudum Andrew's Form 4 filing
Hims & Hers Health, Inc. (HIMS) · filed Feb 20, 2025
- Accession no.
- 0001773751-25-000051
- Filed
- Feb 20, 2025
- Trade date
- Feb 18, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 10 non-derivative transactions and 2 derivative transactions. Open-market sales total $10.2M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dudum AndrewCIK 0001837796 | Director, Officer (Chief Executive Officer), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 18, 2025 | Class A Common Stock | SSaleDisposed | −1,992 | $58.35F2 | −$116,233.2 | 98,487 | Direct | |
| Feb 18, 2025 | Class A Common Stock | SSaleDisposed | −800 | $59.69F3 | −$47,752 | 97,687 | Direct | |
| Feb 18, 2025 | Class A Common Stock | MOption exerciseAcquired | +17,001 | $2.43 | +$41,312.43 | 114,688 | Direct | |
| Feb 18, 2025 | Class A Common Stock | MOption exerciseAcquired | +108,334 | $2.43 | +$263,251.62 | 223,022 | Direct | |
| Feb 18, 2025 | Class A Common Stock | SSaleDisposed | −33,347 | $57.86F4 | −$1,929,457.42 | 189,675 | Direct | |
| Feb 18, 2025 | Class A Common Stock | SSaleDisposed | −81,660 | $58.26F5 | −$4,757,511.6 | 108,015 | Direct | |
| Feb 18, 2025 | Class A Common Stock | SSaleDisposed | −10,328 | $59.57F6 | −$615,238.96 | 97,687 | Direct | |
| Feb 18, 2025 | Class A Common Stock | SSaleDisposed | −14,784 | $57.85F7 | −$855,254.4 | 460,546 | Indirect | |
| Feb 18, 2025 | Class A Common Stock | SSaleDisposed | −31,257 | $58.22F8 | −$1,819,782.54 | 429,289 | Indirect | |
| Feb 18, 2025 | Class A Common Stock | SSaleDisposed | −1,493 | $59.54F9 | −$88,893.22 | 427,796 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 18, 2025 | Class A Common Stock | MOption exerciseDisposed | −17,001 | $0.00 | $0 | 153,013 | Direct | |
| Feb 18, 2025 | Class A Common Stock | MOption exerciseDisposed | −108,334 | $0.00 | $0 | 1,298,067 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $58.10 - $58.84. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $59.60 - $59.88. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $57.62 - $57.995. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $58.00 - $58.91. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F6
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $59.20 - $59.88. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F7
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $57.62 - $57.99. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F8
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $58.00 - $58.84. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F9
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $59.31 - $59.88. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.